Skip to main content
Logo
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
  • News article
  • 13 May 2024
  • European Medicines Agency
  • 1 min read

Draft RWE reflection paper published for public consultation

Five people having a discussion at a table

EMA has published a draft reflection paper on the use of real-world data (RWD) in non-interventional studies to generate real-world evidence (RWE), which discusses methodological and data quality aspects of such studies. The development of this paper is part of the Methodology Working Party Workplan 2022-2024 and the joint HMA-EMA Big Data Steering Group plan 2023-2025.

Interested partners and stakeholders involved in the planning, conduct and analysis of non-interventional studies are invited to provide feedback on the draft reflection paper until 31 August 2024.

The reflection paper will also be presented to gather initial feedback in a dedicated session at the multi-stakeholder joint HMA-EMA workshop on RWE methods on 14 June 2024.

Related information:

Details

Publication date
13 May 2024
Author
European Medicines Agency